CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.12% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money
1.6347
0.61%
  • Summary
  • Historical Data
Trading сonditions
Spread 0.1706
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.023512 %
Charges from full value of position ($-4.47)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.023512%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.00129 %
Charges from full value of position ($0.25)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.00129%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 1.6447
Open 1.6147
1-Year Change 41.95%
Day's Range 1.6147 - 1.7247
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Feb 21, 2025 1.6347 0.0200 1.24% 1.6147 1.7247 1.6147
Feb 20, 2025 1.6447 0.0000 0.00% 1.6447 1.6647 1.6047
Feb 19, 2025 1.6247 -0.0200 -1.22% 1.6447 1.6547 1.6247
Feb 18, 2025 1.6647 0.0000 0.00% 1.6647 1.6847 1.6047
Feb 14, 2025 1.6447 -0.0400 -2.37% 1.6847 1.6947 1.6447
Feb 13, 2025 1.5747 -0.0300 -1.87% 1.6047 1.6647 1.5747
Feb 12, 2025 1.6147 -0.0300 -1.82% 1.6447 1.6647 1.5947
Feb 11, 2025 1.6247 0.0200 1.25% 1.6047 1.6647 1.5647
Feb 10, 2025 1.6747 0.0900 5.68% 1.5847 1.6847 1.5847
Feb 7, 2025 1.6547 -0.0400 -2.36% 1.6947 1.6947 1.6047
Feb 6, 2025 1.6247 -0.0400 -2.40% 1.6647 1.7047 1.6247
Feb 5, 2025 1.6847 0.0300 1.81% 1.6547 1.6947 1.5747
Feb 4, 2025 1.6047 -0.0500 -3.02% 1.6547 1.6947 1.6047
Feb 3, 2025 1.6247 -0.0400 -2.40% 1.6647 1.6647 1.6147
Jan 31, 2025 1.7347 0.0500 2.97% 1.6847 1.7347 1.6847
Jan 30, 2025 1.7247 0.0200 1.17% 1.7047 1.7447 1.6647
Jan 29, 2025 1.6547 -0.0300 -1.78% 1.6847 1.7347 1.6547
Jan 28, 2025 1.7047 0.0500 3.02% 1.6547 1.7847 1.6347
Jan 27, 2025 1.6747 0.0600 3.72% 1.6147 1.6747 1.6047
Jan 24, 2025 1.6647 -0.0200 -1.19% 1.6847 1.6847 1.6147

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

BeyondSpring Inc. Company profile

About Beyondspring Inc

BeyondSpring Inc. is a global biopharmaceutical company that is focused on developing immuno-oncology cancer therapies. The Company’s lead product Plinabulin, which is being studied as an anti-cancer agent in combination with docetaxel in advanced non-small cell lung cancer (NSCLC). The Plinabulin product is a marine-derived small-molecule selective immunomodulating microtubule-binding agent (SIMBA) with a range of immune activities. Its Plinabulin has the immune defense protein, GEF-H1, which leads to two effects: a durable anti-cancer benefits due to the maturation of dendritic cells resulting in activation of tumor antigen-specific T-cells to target cancer cells and early-onset action in chemotherapy-induced neutropenia (CIN) prevention after chemotherapy by boosting the number of hematopoietic stem/progenitor cells (HSPCs).

Financial summary

BRIEF: For the nine months ended 30 September 2021,Beyondspring Inc revenues increased from $0K to $1M. Netloss increased 26% to $54.7M. Revenues reflect an increasein demand for the Company's products and services due tofavorable market conditions. Higher net loss reflectsGeneral and administrative - Balancing increase from $10.2Mto $22M (expense), Stock-based Compensation in SGA increaseof 76% to $3.7M (expense).

Industry: Bio Therapeutic Drugs

28 Liberty Street
39th Floor
NEW YORK
NEW YORK 10005
US

People also watch

ETH/USD

2,779.27 Price
+5.290% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 1.75

Gold

2,936.56 Price
-0.110% 1D Chg, %
Long position overnight fee -0.0149%
Short position overnight fee 0.0067%
Overnight fee time 22:00 (UTC)
Spread 0.30

US100

21,594.40 Price
-2.120% 1D Chg, %
Long position overnight fee -0.0235%
Short position overnight fee 0.0013%
Overnight fee time 22:00 (UTC)
Spread 7.0

BTC/USD

96,674.75 Price
+1.390% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 50.00

Still looking for a broker you can trust?

Join the 690,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading